ClinConnect ClinConnect Logo
Search / Trial NCT05324488

Diabetes Registry Graz for Biomarker Research

Launched by MEDICAL UNIVERSITY OF GRAZ · Apr 5, 2022

Trial Information

Current as of July 23, 2025

Recruiting

Keywords

Cohort Study

ClinConnect Summary

The Diabetes Registry Graz for Biomarker Research is a study designed to better understand diabetes and related conditions, such as obesity and lipid disorders. Researchers are looking to collect important information, blood, and urine samples from people with different types of diabetes, including type 1, type 2, and rarer forms, over several years. This information will help scientists find new ways to improve treatment and management of these conditions.

To join this study, participants need to be between 18 and 99 years old and must agree to take part by signing a consent form. They should have one of the following conditions: type 1 diabetes, type 2 diabetes, specific rare types of diabetes, obesity (defined as a body mass index over 30), or issues with fat metabolism. If you decide to participate, you can expect to provide data and samples once a year. This is a fantastic opportunity to contribute to important research that may help others in the future!

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 18 - 99 years
  • Informed consent has to be given in written form
  • * At least one of the following diseases:
  • Type 1 diabetes
  • Type 2 diabetes
  • Type 3 diabetes
  • Maturity onset diabetes of young (MODY)
  • Late onset diabetes of the adult (LADA)
  • Adipositas (BMI \> 30kg/m2)
  • Lipid metabolism disorder
  • Exclusion Criteria:
  • No written informed consent
  • No willingness to participate in this registry

About Medical University Of Graz

The Medical University of Graz, a leading institution in Austria, is dedicated to advancing medical knowledge and improving patient care through innovative research and clinical trials. Renowned for its interdisciplinary approach, the university collaborates with various healthcare professionals and researchers to explore cutting-edge therapies and treatments. With a commitment to ethical standards and patient safety, the Medical University of Graz actively contributes to the global medical community by facilitating rigorous clinical trials that aim to translate scientific discoveries into practical applications for improved health outcomes.

Locations

Graz, , Austria

Patients applied

BG

1 patients applied

Trial Officials

Harald Sourij, MD

Principal Investigator

Medical University of Graz

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials